Seattle Genetics (SGEN) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Seattle Genetics (SGEN): In Line ADCETRIS Sales Lead to PT Reduction at Piper Jaffray
February 10, 2016 8:57 AM ESTSlowing sales of Seattle Genetics' (NASDAQ: SGEN) ADCETRIS led Piper Jaffray analyst, Edward Tenthoff, to reduce his overall value for the therapy to $1.5 billion from $1.6 billion. This leads to a lower target price for shares of Seattle Genetics of $33 (from $44). The firm maintained a Neutral rating.
ADCETRIS sales grew 27% annually to $226 million in 2015, but we forecast growth will slow to 17% to $265 million (guidance is $255-$275 million) in 2016. ADCETRIS is currently in three Phase III trials that... More
Cantor Fitzgerald Upgrades Seattle Genetics (SGEN) to Buy
February 10, 2016 7:26 AM ESTCantor Fitzgerald upgraded Seattle Genetics (NASDAQ: SGEN) from Hold to Buy with a price target of $38.00.
For an analyst ratings summary and ratings history on Seattle Genetics click here. For more ratings news on Seattle Genetics click here.
Shares of Seattle Genetics closed at $29.04 yesterday.
... More